AVE 0.00% 0.2¢ avecho biotechnology limited

The FDA plans to issue 4 separate guidances on pain products,...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,998 Posts.
    lightbulb Created with Sketch. 18895

    The FDA plans to issue 4 separate guidances on pain products, commencing in the next 6 to 12 months.

    1. Assisting sponsors with the development of non-opioid medications.
    2. Addressing drugs that can spare the use of opioids in the treatment of acute pain. Risks associated with illicit use of treatments for acute pain will be explicitly considered.
    3. Outlining a path for extended-release local anaesthetics.
    4. Outlining the information the FDA will require manufacturers to provide regarding risks and benefits when new opioid pain drugs are put into development.

    The first guidance won’t help POH.

    The second guidance also is unlikely to benefit POH. There is an apparent preference for either avoiding opioids completely or limiting the prescribed opioid to 1-2 days supply (instead of the now-common 30 day prescriptions). Perhaps the one-day TPM patch might have a role to play here?

    The third guidance makes me wonder about the potential of TPM/lidocaine and TPM/ropivicaine.

    The fourth should surely benefit POH. It has a strong case to put forward that the TPM/opioid patch has increased benefits and reduced risk compared with current oral ER opioids.

    https://www.empr.com/news/opioid-cr...analgesics-guidance-documents/article/792186/

    https://www.practicalpainmanagement...tional-opioid-prescribing-starting-acute-pain
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $973 486.2K

Buyers (Bids)

No. Vol. Price($)
11 6361102 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 41925822 29
View Market Depth
Last trade - 10.27am 31/10/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.